Larynx Clinical Trial
— ETTOfficial title:
Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Mallinckrodt® Endotracheal When Using the Glidescope®
The purpose of the study is to determine if there are differences related to ease of intubation reported by clinicians who use the Parker Flex-Tip® endotracheal tubes(ETT)compared to the standard Mallinckrodt® (ETT). The problem is two (ETTs), the Parker Flex-Tip® and the Mallinckrodt®, are currently available for use in operative suites for intubation, but few studies have compared these devices with each other. Two research questions to be answered in the study are 1. Is there a difference in the ease of intubation when the Parker Flex-Tip® (ETT) is used when compared to the standard Mallinckrodt® (ETT)? and 2. Are there differences in the number of successful intubations when comparing the Parker Flex-Tip® (ETT) and the standard Mallinckrodt® (ETT)? The hypotheses are the use of the Parker Flex-Tip® (ETT) will demonstrate: 1. Fewer seconds to intubate the trachea. 2. Higher self-reported ease of placement scores and 3. Fewer redirections to intubate the trachea. The number of successful intubations is expected to be the same in both arms of the study.
Status | Completed |
Enrollment | 60 |
Est. completion date | May 2011 |
Est. primary completion date | May 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Subjects that are males and non-pregnant females > or equal to 18 years of age that require a general anesthetic with an (ETT). 2. Able to give informed consent (adults, English reading and speaking) Exclusion Criteria: 1. Any subject on examination with a mallampati III or greater and/or history of difficult intubation. 2. Any subject with an American Society of Anesthesiologist classification greater than 3. 3. Any subject needing rapid sequence induction. 4. Any subject that the anesthesia provider considers the GlideScope® to be contraindicated. 5. Any subject that an anesthesia provider feels for any reason at any time is not appropriate for inclusion in this study. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)
Country | Name | City | State |
---|---|---|---|
United States | University Hospitals of Cleveland | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
University Hospital Case Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ease of Intubation, as Measured by Time in Seconds for ETT Insertion | To measure the ease of intubation by time in seconds for ETT insertion. Time was measured in seconds and started when the anesthesia provider asked for the ETT and stopped once the ETT was placed through the glottis. The time was obtained from video recordings during the intubation by the principal investigator (PI). | Participants were followed for the duration of intubation, an average of 10 minutes | No |
Primary | Ease of Intubation, as Measured by Number of ETT Redirections | To measure the ease of intubation, once the airway structure was visualized with the GlideScope, the number of ETT redirections at the glottis to intubate the trachea was counted by video recordings by the PI. | Participants were followed for the duration of intubation, an average of 10 minutes | No |
Primary | Ease of Intubation, as Measured by an Ease of ETT Insertion Score. | To measure the ease of intubation, an ease of ETT insertion score was obtained by using a 100 millimeter visual analog scale done by the anesthesia provider doing the intubation. The score of 0 millimeters was the easiest intubation and a score of 100 millimeters was the hardest intubation done by that anesthesia provider. | Participants were followed for the duration of intubation, an average of 10 minutes | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05746780 -
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
|
||
Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
Completed |
NCT02126969 -
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
|
Phase 2 | |
Completed |
NCT03162731 -
Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer
|
Early Phase 1 | |
Enrolling by invitation |
NCT03269396 -
Laryngeal Allograft Transplantation
|
N/A | |
Completed |
NCT01649973 -
Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy
|
N/A | |
Withdrawn |
NCT04168671 -
CLE During Exercise Testing in Asthma
|
N/A | |
Completed |
NCT01321892 -
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
|
N/A | |
Recruiting |
NCT05636410 -
Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
|
||
Recruiting |
NCT05565430 -
Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
|
||
Completed |
NCT03109873 -
Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
|
Early Phase 1 | |
Active, not recruiting |
NCT03737968 -
Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.
|
Phase 2 | |
Recruiting |
NCT03109171 -
Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT02761239 -
Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve
|
N/A | |
Recruiting |
NCT05145556 -
Teach Intubation by Novices in Anaesthesiology
|
N/A | |
Completed |
NCT03030781 -
Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging.
|
N/A | |
Completed |
NCT03238365 -
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
|
Early Phase 1 | |
Withdrawn |
NCT02065128 -
The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome
|
N/A | |
Active, not recruiting |
NCT03854032 -
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
|
Phase 2 | |
Active, not recruiting |
NCT03076281 -
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
|
Phase 2 |